Drawing for MINDERA HEALTH

USPTO serial 97056864

MINDERA HEALTH

Reviewed by CopyMark Law Group

Reg. 7414360Status 700Registered
Filing date
Status date
Registration date
Jun 11, 2024
Examiner
FRENCH, CURTIS W
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MINDERA HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Johnny Manriquez

Johnny Manriquez AH GENERAL COUNSEL SERVICESP.O. BOX QDEL MAR, CA 92014United States

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations for clinical or medical laboratory useACTIVEAug 20, 2021
005Diagnostic preparations for medical or veterinary purposesACTIVEAug 20, 2021
044Medical services; Nucleic acid sequencing and analysis services for medical purposes; Genome sequencing and analysis services for medical purposes; Medical genetic analysis and reporting services for diagnostic, prognostic or treatment uses; Medical testing and analysis for diagnostic and treatment purposes; DNA, RNA, nucleic acid and genetic sequencing, screening, and analysis services for medical purposes; Clinical diagnostic and consultation services for medical purposes in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicineACTIVEAug 20, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 11, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 11, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 8, 2024SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 8, 2024CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 1, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 1, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 11, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 10, 2024IUAFUSE AMENDMENT FILED—
Apr 10, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 10, 2024EX2GSOU EXTENSION 2 GRANTED—
Apr 10, 2024EXT2SOU EXTENSION 2 FILED—
Apr 10, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 3, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 29, 2023EX1GSOU EXTENSION 1 GRANTED—
Sep 29, 2023EXT1SOU EXTENSION 1 FILED—
Sep 29, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 11, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 14, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 14, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 25, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 12, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 5, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 4, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 4, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 6, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 6, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 6, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2022DOCKASSIGNED TO EXAMINER—
Oct 28, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 5, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance